<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The paper demonstrates anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies to be a risk factor in ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> in children </plain></SENT>
<SENT sid="1" pm="."><plain>The function and importance of anticardiolipid antibodies and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> are discussed </plain></SENT>
<SENT sid="2" pm="."><plain>The author recall the definition of the anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome and the resultant neurological disturbances, especially ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> in children </plain></SENT>
<SENT sid="3" pm="."><plain>In a series of 20 patients with cerebral ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> aged 8 months to 16 years and hospitalized in the years 1990-98, anticardiolipid antibodies were determined </plain></SENT>
<SENT sid="4" pm="."><plain>Of 20 patients, 12 children tested positive and preventive aspirin therapy was initiated </plain></SENT>
<SENT sid="5" pm="."><plain>These preliminary results invite further investigations on the role of anticardiolipid antibodies in the pathogenesis of cerebral <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> in children </plain></SENT>
</text></document>